- 睿智醫藥
- 6.700-0.010 (-0.149%)
盈利能力分析
- -4.401
- -48.477
- 16.827
- -18.316
- 6.549
- -2.686
- -29.372
- 9.037
- -9.647
- 3.918
- -3.024
- -32.939
- 10.070
- -10.735
- 4.396
邊際利潤分析
- 19.225
- 25.935
- 25.423
- 31.690
- 38.315
- -9.263
- -82.255
- 56.350
- -21.021
- 13.460
- -8.202
- -81.322
- 55.826
- -16.483
- 16.977
- -8.598
- -80.549
- 27.320
- -23.783
- 10.396
收益指標分析
- 83.072
- 6.392
- -11.315
- 2.377
- 78.224
- -10.895
- 0.098
- 190.871
- -3.061
- 48.711
- 0.717
- 0.362
- -2.575
- 1.559
- -3.061
償債能力分析
- 1.797
- 1.704
- 1.749
- 0.694
- 1.168
- 1.767
- 1.639
- 1.691
- 0.625
- 1.098
- 35.563
- 39.988
- 37.762
- 52.839
- 40.499
- 8.882
- 10.329
- 15.544
- 31.887
- 31.884
- 802.877
- 643.036
- 443.387
- 162.182
- 206.044
- 178.042
- 147.585
- 163.121
- 88.150
- 145.454
- -7.271
- -66.008
- 62.684
- -3.384
- 4.335
營運能力分析
- 87.716
- 95.718
- 91.814
- 76.617
- 96.373
- 8.877
- 15.094
- 20.310
- 19.267
- 24.163
貨幣攻略
回顧24 展望25
More